Wells Fargo’s Akoya BioSciences AKYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-545
| Closed | -$709 | – | 7071 |
|
|
2025
Q2 | $709 | Sell |
545
-12,151
| -96% | -$14.6K | ﹤0.01% | 6342 |
|
|
2025
Q1 | $17.6K | Buy |
12,696
+280
| +2% | +$613 | ﹤0.01% | 5748 |
|
|
2024
Q4 | $28.4K | Buy |
12,416
+4,233
| +52% | +$11.2K | ﹤0.01% | 5669 |
|
|
2024
Q3 | $22.3K | Sell |
8,183
-324
| -4% | -$791 | ﹤0.01% | 5616 |
|
|
2024
Q2 | $19.9K | Buy |
8,507
+1,581
| +23% | +$5.04K | ﹤0.01% | 5587 |
|
|
2024
Q1 | $32.5K | Buy |
6,926
+929
| +15% | +$4.82K | ﹤0.01% | 5418 |
|
|
2023
Q4 | $29.3K | Buy |
5,997
+1,540
| +35% | +$6.4K | ﹤0.01% | 5487 |
|
|
2023
Q3 | $20.7K | Sell |
4,457
-3,191
| -42% | -$18.3K | ﹤0.01% | 5581 |
|
|
2023
Q2 | $56.5K | Buy |
7,648
+4,175
| +120% | +$27.9K | ﹤0.01% | 5378 |
|
|
2023
Q1 | $28.4K | Buy |
3,473
+2,993
| +624% | +$31.3K | ﹤0.01% | 5476 |
|
|
2022
Q4 | $4.59K | Sell |
480
-249
| -34% | -$3.06K | ﹤0.01% | 5796 |
|
|
2022
Q3 | $8K | Sell |
729
-349
| -32% | -$4.6K | ﹤0.01% | 5751 |
|
|
2022
Q2 | $14K | Sell |
1,078
-118,304
| -99% | -$1.23M | ﹤0.01% | 5602 |
|
|
2022
Q1 | $1.31M | Buy |
119,382
+1,021
| +0.9% | +$11.8K | ﹤0.01% | 3663 |
|
|
2021
Q4 | $1.81M | Sell |
118,361
-228,478
| -66% | -$2.99M | ﹤0.01% | 3600 |
|
|
2021
Q3 | $4.84M | Buy |
346,839
+126,062
| +57% | +$2.11M | ﹤0.01% | 2862 |
|
|
2021
Q2 | $4.27M | Buy |
+220,777
| New | +$4.56M | ﹤0.01% | 3000 |
|
Wells Fargo's AKYA Position: Q3 2025 in Review
Wells Fargo sold out of Akoya BioSciences (AKYA) in Q3 2025, closing a stake of 545 shares — an estimated $709 sold.
Wells Fargo first reported a position in AKYA in Q2 2021 and held it in 17 quarters. The position peaked at $4.84M in Q3 2021. 0 funds tracked by Wall St. Rank hold AKYA as of Q3 2025.
- Wells Fargo reported no remaining Akoya BioSciences position as of Q3 2025 after selling out during the quarter.
- Wells Fargo sold 545 Akoya BioSciences shares in Q3 2025, an estimated $709.
- Wells Fargo first reported a position in Akoya BioSciences in Q2 2021 and held it in 17 quarters.
- Wells Fargo's Akoya BioSciences position peaked at $4.84M in Q3 2021.
- 0 funds tracked by Wall St. Rank held Akoya BioSciences as of Q3 2025.
Based on Wells Fargo's 13F filing for Q3 2025, filed 13 Nov 2025.